• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Increased Indoleamine-2,3-Dioxygenase Activity Is Associated With Poor Clinical Outcome in Adults Hospitalized With Influenza in the INSIGHT FLU003Plu

tetano

Editor, Senior Moderator
Open Forum Infect Dis. 2017 Oct 25;5(1):ofx228. doi: 10.1093/ofid/ofx228. eCollection 2018 Jan.
[h=1]Increased Indoleamine-2,3-Dioxygenase Activity Is Associated With Poor Clinical Outcome in Adults Hospitalized With Influenza in the INSIGHT FLU003Plus Study.[/h] Pett SL[SUP]1,[/SUP][SUP]2,[/SUP][SUP]3[/SUP], Kunisaki KM[SUP]4,[/SUP][SUP]5[/SUP], Wentworth D[SUP]6[/SUP], Griffin TJ[SUP]7[/SUP], Kalomenidis I[SUP]8[/SUP], Nahra R[SUP]9[/SUP], Montejano Sanchez R[SUP]10[/SUP], Hodgson SW[SUP]4[/SUP], Ruxrungtham K[SUP]11,[/SUP][SUP]12[/SUP], Dwyer D[SUP]13[/SUP], Davey RT[SUP]14[/SUP], Wendt CH[SUP]4,[/SUP][SUP]5[/SUP]; INSIGHT FLU003 Plus Study Group.
[h=3]Collaborators (195)[/h]

[h=3]Author information[/h]

[h=3]Abstract[/h] [h=4]Background:[/h] Indoleamine-2,3-dioxygenase (IDO) mediated tryptophan (TRP) depletion has antimicrobial and immuno-regulatory effects. Increased kynurenine (KYN)-to-TRP (KT) ratios, reflecting increased IDO activity, have been associated with poorer outcomes from several infections.
[h=4]Methods:[/h] We performed a case-control (1:2; age and sex matched) analysis of adults hospitalized with influenza A(H1N1)pdm09 with protocol-defined disease progression (died/transferred to ICU/mechanical ventilation) after enrollment (cases) or survived without progression (controls) over 60 days of follow-up. Conditional logistic regression was used to analyze the relationship between baseline KT ratio and other metabolites and disease progression.
[h=4]Results:[/h] We included 32 cases and 64 controls with a median age of 52 years; 41% were female, and the median durations of influenza symptoms prior to hospitalization were 8 and 6 days for cases and controls, respectively (P = .04). Median baseline KT ratios were 2-fold higher in cases (0.24 mM/M; IQR, 0.13-0.40) than controls (0.12; IQR, 0.09-0.17; P ≤ .001). When divided into tertiles, 59% of cases vs 20% of controls had KT ratios in the highest tertile (0.21-0.84 mM/M). When adjusted for symptom duration, the odds ratio for disease progression for those in the highest vs lowest tertiles of KT ratio was 9.94 (95% CI, 2.25-43.90).
[h=4]Conclusions:[/h] High KT ratio was associated with poor outcome in adults hospitalized with influenza A(H1N1)pdm09. The clinical utility of this biomarker in this setting merits further exploration.
[h=4]ClinicalTrialsgov Identifier:[/h] NCT01056185.


[h=4]KEYWORDS:[/h] indoleamine-2,3-dioxygenase; influenza; kynurenine; outcome; tryptophan

PMID: 29322062 PMCID: PMC5753217 DOI: 10.1093/ofid/ofx228
Free PMC Article
 
Back
Top